Clinical Trials Browser

Phase 2/3 × olaparib × Clear all

NCT02502266 2026-03-05

Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

Phase 2/3 Active not recruiting

582 enrolled 21 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05255653 2024-11-29

RAINBO

Phase 2/3 Recruiting

Endometrial Neoplasms